Back to Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 6

Update on the treatment of disseminated fusariosis: Focus on voriconazole

Authors Marta Stanzani, Fabio Tumietto, Nicola Vianelli, Michele Baccarani

Published 15 January 2008 Volume 2007:3(6) Pages 1165—1173

Marta Stanzani1, Fabio Tumietto2, Nicola Vianelli1, Michele Baccarani1
1Institute of Haematology and Clinical Oncology “Ariosto e Lorenzo Seràgnoli”, S. Orsola-Malpighi Hospital, University of Bologna, Italy; 2Division of Infectious Diseases, S. Orsola-Malpighi Hospital, University of Bologna, Italy
Abstract: Invasive fungal infections are a major cause of morbidity and mortality in immunocompromised patients, such as subjects with hematological malignancies and patients who underwent to hematopoietic stem cell transplantation (HSCT) or solid organ transplantation (SOT). Fusarium spp. cause a broad spectrum of infections in humans. Immunologically competent hosts show mainly localized skin infections, whereas disseminated fusariosis occurs almost exclusively in immunocompromised patients. Fusarium spp. are resistant to many antifungal agents with equivocal in vitro and in vivo susceptibility to amphotericin B. Voriconazole (VRC) is a triazole shown to be safe, well tolerated, and in vitro efficacious against Fusarium spp. Although clinical experience is limited, many case reports have shown the efficacy of VRC in the treatment of fusariosis.
Keywords: fusariosis, voriconazole, immunocompromised patient, cancer, fungal infections, aspergillus

Download Article [PDF] 

Readers of this article also read:

Paclitaxel attenuates renal interstitial fibroblast activation and interstitial fibrosis by inhibiting STAT3 signaling

Zhang L, Xu X, Yang R, Chen J, Wang S, Yang JQ, Xiang X, He Z, Zhao Y, Dong Z, Zhang D

Drug Design, Development and Therapy 2015, 9:2139-2148

Published Date: 15 April 2015

Manganese-containing Prussian blue nanoparticles for imaging of pediatric brain tumors

Dumont MF, Yadavilli S, Sze RW, Nazarian J, Fernandes R

International Journal of Nanomedicine 2014, 9:2581-2595

Published Date: 23 May 2014

Causal diagrams and the logic of matched case-control studies

Shahar E, Shahar DJ

Clinical Epidemiology 2012, 4:137-144

Published Date: 15 May 2012

How can micelle systems be rebuilt by a heating process?

Silva-Filho MA, Siqueira SDVS, Freire LB, Araújo IB, Silva KGH, Medeiros AC, Araújo-Filho I, Oliveira AG, Egito EST

International Journal of Nanomedicine 2012, 7:141-150

Published Date: 12 January 2012

Toxicologic effects of gold nanoparticles in vivo by different administration routes

Xiao-Dong Zhang, Hong-Ying Wu, Di Wu, et al

International Journal of Nanomedicine 2010, 5:771-781

Published Date: 28 September 2010

Urotensin II-induced signaling involved in proliferation of vascular smooth muscle cells

Myriam Iglewski, Stephen R Grant

Vascular Health and Risk Management 2010, 6:723-734

Published Date: 11 August 2010

Are pleiotropic effects of statins real?

Alberto Corsini, Nicola Ferri, Michele Cortellaro

Vascular Health and Risk Management 2007, 3:611-613

Published Date: 15 November 2007

Bisoprolol in the treatment of chronic heart failure: from pathophysiology to clinical pharmacology and trial results

Marco Metra, Savina Nodari, Tania Bordonali, Patrizia Milani, Carlo Lombardi, et al

Therapeutics and Clinical Risk Management 2007, 3:569-578

Published Date: 15 September 2007